Leinco Technologies offers over 25 years of demonstrated success in monoclonal antibody development for demanding applications such as early discovery research, in vivo preclinical therapeutic investigations, and in vitro diagnostics. Capabilities include antibodies developed in mice or Armenian hamsters against soluble proteins, cell surface molecules, or haptens for use in detection, neutralization or in vivo depletion. Utilizing proprietary development technologies, our scientific staff is skilled at producing monoclonal antibodies against single amino acid substitutions, splice variants and for neutralization.
Superior mAb Performance Using Mice or Hamsters
Leinco Technologies uniquely offers monoclonal antibody development using both mice or hamsters as host animals. Importantly, the use of hamster as the host animal offers the unique advantage of producing antibodies that can be used in vivo in mouse models without eliciting an immune response against the injected antibody.